These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35122575)

  • 61. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Knowledge and attitudes of HIV pre-exposure prophylaxis among nurses in South Africa.
    Bailey VC; Kleinhans AV; Mokgatle MM
    Afr J Prim Health Care Fam Med; 2023 Sep; 15(1):e1-e6. PubMed ID: 37916728
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
    Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
    Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
    Dietrich JJ; Atujuna M; Tshabalala G; Hornschuh S; Mulaudzi M; Koh M; Ahmed N; Muhumuza R; Ssemata AS; Otwombe K; Bekker LG; Seeley J; Martinson NA; Terris-Prestholt F; Fox J
    BMC Health Serv Res; 2021 Jan; 21(1):17. PubMed ID: 33407395
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Healthcare provider knowledge and attitudes about pre-exposure prophylaxis (PrEP) in pregnancy in Cape Town, South Africa.
    Joseph Davey DL; Daniels J; Beard C; Mashele N; Bekker LG; Dovel K; Ncayiyana J; Coates TJ; Myer L
    AIDS Care; 2020 Oct; 32(10):1290-1294. PubMed ID: 32576023
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Four years later: Do South Africans know what pre-exposure prophylaxis for HIV is?
    Haffejee F; Fasanmi-Kana O; Ally F; Thandar Y; Basdav J
    AIDS Care; 2023 Apr; 35(4):466-473. PubMed ID: 35109735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
    Naicker CL; Mansoor LE; Dawood H; Naidoo K; Singo D; Matten D; Williamson C; Abdool Karim Q
    BMC Infect Dis; 2020 Jul; 20(1):532. PubMed ID: 32698772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017.
    Miner MD; Bekker LG; Kredo T; Bhagwandin N; Corey L; Gray GE
    Trials; 2021 Nov; 22(1):778. PubMed ID: 34742340
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents.
    LoVette A; Kuo C; Giovenco D; Hoare J; Underhill K; Operario D
    SAHARA J; 2022 Dec; 19(1):1-7. PubMed ID: 35135437
    [TBL] [Abstract][Full Text] [Related]  

  • 73. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.
    Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA;
    Lancet HIV; 2018 Nov; 5(11):e629-e637. PubMed ID: 30343026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa.
    Montgomery ET; Roberts ST; Reddy K; Tolley EE; Hartmann M; Mathebula F; Wagner LD; Lanham M; Wilcher R; Browne EN; Baeten JM; Palanee-Phillips T
    J Acquir Immune Defic Syndr; 2022 Aug; 90(4):425-433. PubMed ID: 35416797
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
    PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peer-to-Peer Chain Recruitment for Enrolling Young South African Women into an HIV Pre-exposure Prophylaxis (PrEP) Intervention Study: How Did It Perform?
    Fordjuoh J; Dolezal C; Bhengu N; Harrison AD; Exner TM; Hanass-Hancock J; Hoffman S
    AIDS Behav; 2024 May; 28(5):1782-1794. PubMed ID: 38416275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa.
    Makhakhe NF; Sliep Y; Meyer-Weitz A
    Front Public Health; 2022; 10():691729. PubMed ID: 35784260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa.
    Little KM; Flomen L; Hanif H; Anderson SM; Thurman AR; Clark MR; Doncel GF
    AIDS Behav; 2022 Sep; 26(9):3099-3109. PubMed ID: 35360893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.